{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:45Z","timestamp":1791561285260,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T02:22:21Z","timestamp":1555467741000},"page":"1637-1641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Vi P.","family":"Doan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Gulbis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Ariza-Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.04.013_bib0001","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2012.0146","article-title":"Prevention and treatment of cancer-related infections","volume":"10","author":"Baden","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0002","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tombyln","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2019.04.013_bib0003","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifield","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0004","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0005","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bbmt.2019.04.013_bib0006","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bbmt.2019.04.013_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0008","doi-asserted-by":"crossref","unstructured":"Slavin M.A., Worth L.J., Seymour J.F., et al. Better sepsis management rather than fluoroquinolone prophylaxis for patients with cancer-related immunosuppression [e-pub ahead of print]. J Clin Oncol. doi:10.1200\/JCO.18.01474, accessed March 29, 2019.","DOI":"10.1200\/JCO.18.01474"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0009","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.clinthera.2014.04.013","article-title":"Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series","volume":"36","author":"Wojenski","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/bmt.2009.216","article-title":"The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation","volume":"45","author":"Guthrie","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.diagmicrobio.2016.01.005","article-title":"Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients","volume":"85","author":"Abidi","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.013_bib0012","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkx338","article-title":"A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukemia patients during chemotherapy-induced neutropenia","volume":"73","author":"Yemm","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.bbmt.2019.04.013_bib0013","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1002\/ajh.25236","article-title":"Antibiotic practice patterns in hematopoietic cell transplantation: a survey of blood and marrow transplant clinical trials network centers","volume":"93","author":"Rashidi","year":"2018","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.bbmt.2019.04.013_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbmt.2012.08.016","article-title":"Bacteremia in blood or marrow transplant patients: clinical risk factors for infection and emerging antibiotic resistance","volume":"19","author":"Bock","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:29:30Z","timestamp":1738009770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119302368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119302368"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}